Edition:
United Kingdom

Galapagos NV (GLPG.AS)

GLPG.AS on Amsterdam Stock Exchange

149.95EUR
22 Aug 2019
Change (% chg)

€-3.35 (-2.19%)
Prev Close
€153.30
Open
€153.00
Day's High
€153.80
Day's Low
€148.90
Volume
241,921
Avg. Vol
395,176
52-wk High
€171.20
52-wk Low
€74.48

About

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and... (more)

Overall

Beta: 1.55
Market Cap(Mil.): €8,733.32
Shares Outstanding(Mil.): 54.82
Dividend: --
Yield (%): --

Financials

  GLPG.AS Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.15 -- --
ROI: -6.22 7.52 12.69
ROE: -6.52 7.94 17.13

Factbox: Who is next in big pharma's merger spree?

Consolidation in the U.S. healthcare industry, which has already witnessed a string of multi-billion dollar deals, is expected to remain a major theme for the rest of 2019.

20 Aug 2019

Who is next in big pharma's merger spree?

Consolidation in the U.S. healthcare industry, which has already witnessed a string of multi-billion dollar deals, is expected to remain a major theme for the rest of 2019.

19 Aug 2019

S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high

NEW YORK The benchmark S&P 500 index ended little changed on Monday after oscillating between positive and negative territory throughout the session after Citigroup Inc kicked off the earnings season with a mixed quarterly report. | Video

15 Jul 2019

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares more than 18% to an all-time high on Monday.

15 Jul 2019

US STOCKS-S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high

* Boeing drops on report 737 MAX groundings could extend to 2020

15 Jul 2019

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion (£4.1 billion) in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares more than 18% to an all-time high on Monday.

15 Jul 2019

UPDATE 4-Gilead invests $5 bln to deepen ties with biotech Galapagos

* Gilead makes $3.95 bln upfront payment, $1.1 equity investment

15 Jul 2019

US STOCKS-S&P trades near flat as Citigroup results weigh on bank stocks

* Dow flat, S&P flat, Nasdaq up 0.18% (Updates to late afternoon New York trade, changes byline, adds NEW YORK to dateline)

15 Jul 2019

US STOCKS-Wall Street slightly lower as Citi results weigh on bank stocks

* Indexes down: Dow 0.12%, S&P 0.15%, Nasdaq 0.07% (Updates to early afternoon)

15 Jul 2019

Deals of the day-Mergers and acquisitions

July 15 The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Monday:

15 Jul 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates